Target intelligence / Profile preview

AGBL5 intronic transcript 1 (AGBL5-IT1)

Target
AGBL5-IT1
Molecular classification
lncRNA, non-coding RNA
01

Overview

AGBL5 intronic transcript 1 (AGBL5-IT1) is a long non-coding RNA (lncRNA) transcribed from within an intron of the AGBL5 gene, also known as AGBL5 intronic transcript 1 RNA. There is currently no evidence that AGBL5-IT1 encodes a protein or functions as a traditional drug target such as a receptor, enzyme, transporter, or transcription factor. No well-characterized biological functions, disease associations, or pharmacological interactions have been described for AGBL5-IT1 in available scientific resources[1]. The confusion likely arises because "AGBL5-IT1" refers specifically to a non-coding RNA, not the protein-coding gene AGBL5 (ATP/GTP binding protein-like 5, also called Cytoplasmic Carboxypeptidase 5 or CCP5)[5]. The protein AGBL5 is an established target in rare retinal diseases, but AGBL5-IT1 lacks established molecular functions, druggability, or disease roles[1]. The literature and databases confirm that AGBL5-IT1 is not considered a therapeutic target and lacks known aliases, biological function, disease involvement, or associated drugs[1]. If information on the *protein-coding* AGBL5 gene is of interest, details on its role in retinitis pigmentosa and other ciliopathies are available, but those are not applicable to the AGBL5-IT1 lncRNA[2][3][4][5].

Other names
AGBL5 intronic transcript 1 RNA

Beyond the preview

Go deeper on AGBL5 intronic transcript 1 (AGBL5-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGBL5 intronic transcript 1 (AGBL5-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call